Accendra Health, Inc. (ACH)
NYSEHealth CareMedical - DistributionSnapshot 2026-09-04
$1.21-0.82%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DistributionSnapshot 2026-09-04
QuarterlyIQ Insights · ACH
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -65.0% |
| Our one-year growth estimate | diamond | -2.1% |
Growth built into the price is above our model estimate.
The price assumes 62.9 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 4 industry peers
ACH — CEO transition
Dated 2026-08-10
CEO — Edward A. Pesicka: The CEO announced a planned retirement with a stated intention to step down by end of 2026 or upon successor appointment, indicating an orderly succession rather than a sudden loss.
Why it matters: Cutting debt makes the company more stable. It also helps investors feel confident.
Supportive ifThe company announces more debt reduction after the $385 million cut in Q2 2026.
Worry ifThe company reports no further debt reduction or increases in debt levels.
Why it matters: If sector revenue growth speeds up, it could help Accendra's performance. This would signal a better environment.
Supportive ifSector revenue growth increases back toward 10% or higher.
Worry ifSector revenue growth continues to slow below 10%.
Why it matters: Progress on this initiative can mean future revenue growth and success. It shows strategic focus.
Supportive ifAccendra Health updates on the launch of the Sleep Center of Excellence across the country.
Worry ifNo updates or delays in the rollout of the Sleep Center of Excellence.
Why it matters: Smaller operating losses show better cost management. This is important for making money in the future.
Supportive ifThe operating loss is now $(35.2) million in Q2 2026. This is better than before.
Worry ifOperating loss widens beyond $(39.7) million seen in Q2 2025.
Why it matters: Fixing debt can make finances stronger and lower debt levels. This is important for growth.
Supportive ifSuccessful completion of the exchange offers for 2029 and 2030 Notes by June 25, 2026.
Worry ifFailure to complete the exchange offers by the deadline.
Why it matters: The company is on track for financial recovery. This makes investors feel better about the future.
Supportive ifThe company confirms 2026 revenue will be between $2.45 billion and $2.55 billion.
Worry ifThe company lowers its revenue or EBITDA guidance for 2026.
Why it matters: Free cash flow is crucial for financial health. Progress here indicates better capital management.
Supportive ifManagement gives a clear update on efforts to generate free cash flow.
Worry ifThere are no updates or negative comments about free cash flow generation.
Why it matters: The company can keep revenue steady even after recent drops. This helps build investor trust.
Supportive ifQ2 revenue meets or exceeds the guidance range of $2.55 billion to $2.65 billion.
Worry ifQ2 revenue falls below $2.55 billion.
Why it matters: The company confirms its guidance. This shows it is recovering financially. Investors feel reassured.
Supportive ifAccendra Health affirms 2026 revenue guidance of $2.45B-$2.55B and adjusted EBITDA of $300M-$320M.
Worry ifThe company lowers its revenue or EBITDA guidance. This is below the current targets.
Why it matters: Operating income shows how well the company controls costs when revenue falls.
Worry ifOperating income will stay above $15 million in Q2, even with lower revenue.
Less concerning ifOperating income drops below $15 million in Q2.
Why it matters: Fixing debt is important for financial health and future growth.
Supportive ifThe debt restructuring is done. This lowers debt and extends payment times.
Worry ifNot completing the restructuring or having more debt is a concern.
Why it matters: Managing costs well is important for making more money and running smoothly.
Supportive ifThe company says it will cut operating costs more. This is on top of the $125 million already cut.
Worry ifOperating expenses go up or do not improve from where they are now.
Why it matters: A buyback can show management's confidence. It can also help increase shareholder value.
Supportive ifManagement announces the start of the share buyback program with details.
Worry ifNo updates on the buyback program or cancellation of the plan.
Why it matters: Successful debt restructuring can improve financial stability and reduce interest costs. It is key for long-term growth.
Supportive ifAccendra Health reduces more debt. This is beyond the $385 million cut in Q2.
Worry ifThe company does not complete planned debt restructuring. It may also have more debt.
Why it matters: A new CEO can shift company strategy and impact stock performance. Leadership changes often create uncertainty.
Watch forAccendra Health announces a new CEO by the end of 2026.
Also watch forNo announcement of a new CEO by the end of 2026.
Why it matters: Good expense management can help make more money and improve cash flow soon.
Supportive ifOperating expenses drop a lot. This shows good cost management.
Worry ifOperating expenses stay high or increase. This shows poor cost management.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$289 on $10,000 · ±2.9% | How much price usually moves either way. |
| Bad day | $995 loss on $10,000 · 9.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,308 loss on $10,000 · 83.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.